IL13RA2 and glioblastoma: It is well documented that IL13RA2‐targeted therapies have gained considerable effect in tumor treatment, such as IL13RA2 monoclonal antibody 24 and IL13R‐specific chimeric antigen receptor‐modified T cells 25, 26 for glioblastoma multiforme.